ArabicChineseEnglishFrenchRussianSpanish
CIPIHCIPIH
All WHO
This site only
  Commission on Intellectual Property Rights, Innovation and Public Health (CIPIH)

Submissions

Kevin Outterson of West Virginia University College of Law
2 February 2006

Patent Buy-Outs For Global Disease Innovations For Low- and Middle-Income Countries [pdf 492kb]
Fair followers: Expanding access to generic pharmaceuticals for low-income populations [pdf 352kb]

Dr Andrew Gilman, Professor Ted Schrecker, Dr Robert Clarke, Robert Hawkes, Institute of Population Health, Canada
21 November 2005

Innovation in Public Health to Reduce Major Health Risks for Developing Countries [pdf 229kb]

USP International Health Expert Committee
21 November 2005

How Does the Regulatory Framework Affect Incentives for Research and Development? [pdf 648kb]

Donald W. Light, Professor of Comparative Health Care Systems, University of Medicine and Dentistry of New Jersey
3 November 2005

Making Practical Markets for Vaccines [pdf 582kb]

Itaru Nitta, School of International Service, American University, Washington, D.C. and Wakabayashi Intellectual Property Law, Tokyo
29 September 2005

Patents and Essential Medicines: an Application of the Green Intellectual Property Project [pdf 204kb]

Dr Tim Hubbard, Head of Human Genome Analysis, Sanger Institute
22 August 2005

Reply to the comments requested by CIPIH and WHO to the CPTech proposal for a Medical Research and Development Treaty [pdf 212kb]

Professor Luigi Orsenigo, University of Brescia
26 July 2005

Review of CPTech Proposal for an R&D Treaty [pdf 67kb]

Frederick Abbott, Professor of International Law, Florida State University
26 July 2005

The WTO Medicines decision: World Pharmaceutical Trade and the Protection of Public Health [pdf 357kb]

Mickey Kantor, former US Trade Representative
25 July 2005

U.S Free Trade Agreements and the Public Health [pdf 1.80Mb]

Bryan Schwartz, Faculty of Law, University of Manitoba
9 June 2005

Economic Prizes: Filling the Gaps in Pharmaceutical Innovation (2005) [pdf 231kb]

International Chamber of Commerce (ICC)
7 June 2005

The importance of incremental innovation for development [pdf 632kb]

Dr Fabio Pammolli, Dr Maria Alessandra Rossi
28 May 2005

Intellectual Property, Technological Regimes and Market Dynamics [pdf 812kb]

Biomedical Industry Advisory Group (BIAG)
26 May 2005

Link to Submissions (BIAG website)

World Intellectual Property Secretariat
20 May 2005

Follow-on Innovation and Intellectual Property [pdf 216kb]

Michael Kremer, Adrian Towse, Heidi Williams
19 May 2005

Briefing Note on Advance Purchase Commitments [pdf 207kb]

Roy Widdus
17 May 2005

Key Stakeholders and Funding of HIV and Malaria Vaccines: Considerations in selecting appropriate instruments for accelerating the public health impact of vaccination in poorer countries [pdf 408kb]

Executive Summary [pdf 175kb]

André Luis de Almeida dos Reis, Carlos Maria Correa, Egléubia Andrade de Oliveira, Gabriela Costa Chaves, Germán Velasquez
10 May 2005

Intellectual Property in the Context of the WTO TRIPS Agreements [pdf 627kb]

Owen Barder, Michael Kremer, Ruth Levine
10 May 2005

Answering concerns about Making Markets for Vaccines [pdf 56kb]

Wendy Taylor of BIO Ventures for Global Health
10 May 2005

Making Markets for Vaccines – A Historic Call for Action [pdf 86kb]

Andrew Farlow, Donald, W. Light, Richard, T. Mahoney,
Roy Widdus
2 May 2005

Concerns Regarding the "Making Markets for Vaccines" [pdf 484kb]

Jean O. Lanjouw of the Center for Global Development
24 April 2005

Outline of the Foreign Filing License Approach [pdf 178kb]

Andrew Farlow from Oxford University
23 March 2005

The Global HIV Vaccine Enterprise, Malaria Vaccines, and Purchase Commitments: What is the Fit ? [pdf 1.09Mb]

Julian Morris, Philip Stevens & Alec van Gelder from the International Policy Network
18 March 2005

Incentivising research and development for the diseases of poverty [pdf 373kb]

Albert Wertheimer from the International Policy Network
17 March 2005

Pharmacoevolution: the benefits of incremental innovation [pdf 373kb]

Robert Sauer of the International Policy Network
9 March 2005

Reducing barriers to the development of high quality, low cost medicines: a proposal for reforming the drug approval process [pdf 214kb]

Bradly J Condon and Tapen Sinha of Instituto Tecnologico Autonomo de Mexico, Mexico
3 March 2005

Global Diseases, Global Patents and Differential Treatment in WTO Law [pdf 108kb]

International Policy Network
1 March 2005

Diseases of poverty and the 10/90 gap [pdf 312kb]

CPTech
24 February 2005

CPTech Letter concerning "Request to Evaluate Proposal for New Global R&D Treaty" [pdf 157kb]

Aidan Hollis of the University of Calgary
5 April 2005

Optional Rewards for New Drugs for Developing Countries ( Updated 5.4.2005) [pdf 242kb]

Mary Moran of LSE Pharmaceutical R&D Policy Group
7 February 2005

Fast Track Options as a fundraising mechanism to support R&D into Neglected Diseases [pdf 1.22Mb]

* The author welcomes comments on this paper. Please send any comments you wish to make to M.Moran@lse.ac.uk.

Mary Moran of LSE Pharmaceutical R&D Policy Group
24 January 2005

New approaches to funding drug R&D for neglected diseases (Powerpoint) [pdf 359kb]

Kevin Outterson of West Virginia University College of Law
3 January 2005

Nonrival access to pharmaceutical knowledge [pdf 36kb]

Ken Kaitin of Tufts University
2 December 2004

The Economics of Follow-on Drug Research and Development- Trends in Entry Rates and the Timing of Development [pdf 553kb]

Kevin Outterson of West Virginia University College of Law
13 November 2004

Pharmaceutical Arbitrage: Balancing Access and Innovation in International Prescription Drug Markets (revised) [pdf 845kb]

Kevin Outterson of West Virginia University College of Law
13 November 2004

Resolving dysfunctional pharmaceutical arbitrage and counterfeit drugs through the proposed Pharmaceutical R&D Treaty [pdf 116kb]

Owen Barder of the Center for Global Development
03 November 2004

Making Markets for Vaccines- A practical plan to spark innovations for global health [pdf 686kb]

Kevin A. Hassett of the American Enterprise Institute
12 October 2004

Price Controls and the Evolution of Pharmaceutical Markets [pdf 403kb]

John E. Calfee of the American Enterprise Institute and Roger Bate of the American Enterprise Institute and Africa Fighting Malaria
12 October 2004

Pharmaceuticals and the Worldwide HIV Epidemic: Can a Stakeholder Model Work? [pdf 280kb]

Dean Baker of "Center for the Economic and Policy Research (CEPR)"
22 September 2004

Financing Drug Research: What are the Issues? [pdf 107kb]

Swiss Federal Institute of Intellecutal Property
27 August 2004

Comments of the Swiss Federal Institute of Intellectual Property on the Commission on Intellectual Property Rights, Innovation and Public Health Framework Paper [pdf 19kb]

Kevin Outterson of West Virginia University College of Law
21 July 2004

Pharmaceutical Arbitrage: balancing access and innovation in international prescription drug markets [pdf 845kb]

Aidan Hollis of the University of Calgary
6 July 2004

An Efficient Reward System for Pharmaceutical Innovation [pdf 297kb]

Ken Kaitin of Tufts University
25 June 2004

Patents and R&D Incentives: Comments on the Hubbard and Love Trade Framework for Financing Pharmaceutical R&D" by Joseph A. DiMasi et Henry G. Grabowski [pdf 63kb]

World Intellectual Property Organization (WIPO)
14 April 2004

Preliminary comments of WIPO to the WHO Commission on Intellectual Property Rights, Innovation and Public Health [pdf 83kb]

Essential Inventions, Inc.
5 April 2004

Statement of Essential Inventions to the Commission on Intellectual Property Rights, Innovation and Public Health [pdf 104kb]



CONTACT

Secretariat for the Commission on
Intellectual Property Rights, Innovation and Public Health (CIPIH)
World Health Organization
20 avenue Appia
CH-1211 Geneva 27
Switzerland
Fax: +41 22 791 4852
E-mail: cipih@who.int